Similar Articles
The Metabolic Syndrome: A Cancer Risk Factor?
Ayça Nur Demir, Kerem Can Tunç, Mehtap Odabaşı, Oytun Erbaş
DOI: 10.5606/jebms.2023.1040
Emerging Immunotherapeutic Approaches for Managing Metastasis
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2023.1050
Revisiting Gene Therapy Approaches for Beta-Thalassemia
Ayşenur Saygılı, Oytun Erbaş
DOI: 10.5606/jebms.2023.1052
Nasopharyngeal Carcinoma: Causes and Incidence
Fatih Özgür Sarıbıyık, Oytun Erbaş
DOI: 10.5606/jebms.2023.1060
Regulatory T Cells and Their Implications in Cancer Immunotherapy
Saime Sıla Gemici, Oytun Erbaş
DOI: 10.5606/jebms.2023.1064
Stem Cell Applications: A Promising Future for Autoimmune Diseases?
Öznur Safgöl, Oytun Erbaş
DOI: 10.5606/jebms.2024.1075
Cancer Stem Cells
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2024.1083
Stem Cell Therapy in Cancer
Ayça Nur Demir, Oytun Erbaş
DOI: 10.5606/jebms.2024.1084
Enteral Nutrition in Cancer Patients
Gamze Nur Yüksel, Oytun Erbaş
DOI: 10.5606/jebms.2024.1089
Coffee Intake and Cancer Risk: Exploring the Relationship
Zehra Betül Aydın, Oytun Erbaş
DOI: 10.5606/jebms.2024.1091
Aspirin and NSAIDs as Cancer Preventive Agents: A Review
Nadin Bedikyan, Oytun Erbaş
DOI: 10.5606/jebms.2024.1093
HERG1 and Cancer: Exploring the Nexus Between Ion Channels and Tumorigenesis
Alper Demirezen, Oytun Erbaş
DOI: 10.5606/jebms.2024.1100
The Role of STAT3 in Cancer Development and Progression
Gökçen Kılınç, Oytun Erbaş
DOI: 10.5606/jebms.2024.1101
Histone Deacetylase Inhibitors in Cancer Treatment
Şule Demirkasaoğlu, Oytun Erbaş
DOI: 10.5606/jebms.2024.1102